- Home
- JAZZ vs OTEX Comparison
JAZZ vs OTEX Comparison
Compare JAZZ & OTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- OTEX
- Stock Information
- Founded
- JAZZ 2003
- OTEX 1991
- Country
- JAZZ Ireland
- OTEX Canada
- Employees
- JAZZ N/A
- OTEX N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- OTEX EDP Services
- Sector
- JAZZ Health Care
- OTEX Technology
- Exchange
- JAZZ Nasdaq
- OTEX Nasdaq
- Market Cap
- JAZZ 8.1B
- OTEX 7.8B
- IPO Year
- JAZZ 2007
- OTEX 1998
- Fundamental
- Price
- JAZZ $136.01
- OTEX $26.83
- Analyst Decision
- JAZZ Strong Buy
- OTEX Hold
- Analyst Count
- JAZZ 14
- OTEX 8
- Target Price
- JAZZ $177.50
- OTEX $32.71
- AVG Volume (30 Days)
- JAZZ 688.4K
- OTEX 784.9K
- Earning Date
- JAZZ 02-25-2025
- OTEX 02-06-2025
- Dividend Yield
- JAZZ N/A
- OTEX 3.91%
- EPS Growth
- JAZZ 458.10
- OTEX 421.00
- EPS
- JAZZ 7.04
- OTEX 2.45
- Revenue
- JAZZ $3,992,712,000.00
- OTEX $5,412,785,000.00
- Revenue This Year
- JAZZ $7.53
- OTEX N/A
- Revenue Next Year
- JAZZ $6.94
- OTEX $2.70
- P/E Ratio
- JAZZ $19.42
- OTEX $10.95
- Revenue Growth
- JAZZ 5.23
- OTEX N/A
- 52 Week Low
- JAZZ $99.06
- OTEX $26.81
- 52 Week High
- JAZZ $138.27
- OTEX $40.55
- Technical
- Relative Strength Index (RSI)
- JAZZ 68.46
- OTEX 36.92
- Support Level
- JAZZ $134.56
- OTEX $27.83
- Resistance Level
- JAZZ $138.27
- OTEX $28.80
- Average True Range (ATR)
- JAZZ 3.56
- OTEX 0.95
- MACD
- JAZZ 1.17
- OTEX -0.23
- Stochastic Oscillator
- JAZZ 88.20
- OTEX 0.40
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About OTEX Open Text Corporation
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.